APA (7th ed.) Citation

AC, B., M, L., CC, K., E, B., X, W., CM, C., . . . JS, P. (2019). Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor. Arteriosclerosis, thrombosis, and vascular biology, 39(9), 1747. https://doi.org/10.1161/ATVBAHA.119.312382

Chicago Style (17th ed.) Citation

AC, Bashore, et al. "Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor." Arteriosclerosis, Thrombosis, and Vascular Biology 39, no. 9 (2019): 1747. https://doi.org/10.1161/ATVBAHA.119.312382.

MLA (9th ed.) Citation

AC, Bashore, et al. "Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor." Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 39, no. 9, 2019, p. 1747, https://doi.org/10.1161/ATVBAHA.119.312382.